Literature DB >> 225358

Correlation between cyclic AMP levels and calcium efflux in isolated renal cortical tubules.

R W Wrenn, D M Biddulph.   

Abstract

Isolated renal cortical tubules from male hamsters were utilized to examine the possible relationship between cyclic AMP (cAMP) and efflux of calcium. Both parathyroid hormone (PTH) and prostaglandin E1 (PGE1) produced dose-related increases in cAMP levels and calcium efflux from isolated tubules. Maximal concentrations of both hormones resulted in changes in cAMP which were 6 fold greater and changes in calcium efflux which were 2 fold greater with PGE1 than with PTH. Effects of sub-maximal amounts of either hormone on both cAMP and calcium efflux were potentiated to tubule incubations resulted in increases in tissue-associated cAMP over the same degree by inclusion of methyl-isobutylxanthine (MIX). Addition of either exogenous cAMP or dibutyryl cAMP (db-cAMP) produced dose-related increases in calcium efflux which occurred more rapidly with db-cAMP than with cAMP. Increasing amounts of cAMP added to the same concentration range resulting in increases in calcium efflux. Addition of 2', 3' cyclic AMP, 5'AMP or db-cyclic GMP had no significant effect on calcium efflux while 3', 5' cyclic CMP significantly reduced this response. The results indicate that cAMP increases efflux of calcium from renal tubules and may play a central role in hormone-dependent transport of this ion.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225358

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Res        ISSN: 0095-1544


  2 in total

1.  The control of growth of mouse mastocytoma cells by N6,O2'-dibutyryladenosine cyclic 3',5'-monophosphate.

Authors:  A Knightbridge; R K Ralph
Journal:  Mol Cell Biochem       Date:  1981-02-11       Impact factor: 3.396

2.  Mechanism of effect of dibutyryl cyclic adenosine 3',5'-monophosphate on canine renal renin release.

Authors:  N Bondar; P Cadnapaphornchai; F D McDonald; S Taher
Journal:  J Physiol       Date:  1984-10       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.